Loading live market data…

BioCryst Pharmaceuticals, Inc.

NASDAQ:BCRX

$9.74 USD

-$0.17 (-1.72%)

Volume
3.96M
Average Volume
5.05M
Market Capitalization
$2.04B
P/E Ratio
-5.63
Dividend Yield
0.00%
Price Target
$17.00
Year High
$11.22
Year Low
$6.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.91

BCRX Estimated and Actual Revenue by Quarter

BCRX Estimated and Actual EPS by Quarter

BCRX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 -50.38M -48.92M -49.51M -51.18M -49.7M -50.3M
2027-09-30 3 -49.42M -47.99M -48.57M -50.2M -48.75M -49.34M
2027-06-30 3 -47.97M -46.58M -47.14M -48.73M -47.32M -47.89M
2027-03-31 3 -42.43M -41.21M -41.7M -43.11M -41.86M -42.37M
2026-12-31 5 -42.6M -41.37M -41.87M -43.28M -42.03M -42.54M
2026-09-30 6 -41M -40.68M -40.84M -41.66M -41.33M -41.49M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 50.26M 52.21M 51.05M 118.4M 121.92M 119.82M
2027-09-30 3 47.97M 49.83M 48.73M 116.12M 119.59M 117.53M
2027-06-30 3 42.52M 44.17M 43.19M 112.72M 116.08M 114.08M
2027-03-31 3 26.08M 27.09M 26.49M 99.72M 102.69M 100.92M
2026-12-31 5 30.9M 32.1M 31.39M 100.11M 103.1M 101.32M
2026-09-30 6 20.2M 20.99M 20.52M 98.44M 99.23M 98.83M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 198.73M 204.65M 201.12M 1 0.20746 0.21553 0.21073
2027-09-30 3 194.91M 200.72M 197.27M 1 0.19801 0.20571 0.20113
2027-06-30 3 189.2M 194.84M 191.49M 1 0.17551 0.18233 0.17827
2027-03-31 3 167.38M 172.36M 169.4M 1 0.10764 0.11182 0.10933
2026-12-31 5 168.04M 173.05M 170.07M 1 0.12755 0.13251 0.12956
2026-09-30 6 165.23M 166.55M 165.89M 2 0.083381 0.08662387 0.084694